Are protocol graft biopsies after pediatric liver transplantation useful? Experience in a single center over 20 years
Clinical Transplantation · 2023
DOI: 10.1111/ctr.14898 ↗At a glance
Studienprotokoll in Clinical Transplantation, 2023. Written by Emma Wischlen and 9 co-authors. Institution: Department of Pediatric Hepatogastroenterology and Nutrition, Femme-Mère-Enfant Hospital, Hospices Civils de Lyon, Lyon, France. Major MEDLINE topics: Liver Transplantation. Cited 2 times so far (Crossref); 26 references.
Abstract (original language)
Background
The role of protocol liver biopsies (PLB) in the follow‐up of pediatric liver transplant recipients remains questionable. This single‐center retrospective study aimed to evaluate their clinical impact on the long‐term management of pediatric liver transplant recipients.
Methods
We described histopathological lesions and clinical consequences for patient management of PLB performed 1, 5, 10, 15, 20, and 25 years after pediatric liver transplantation (LT).
Results
A total of 351 PLB performed on 133 patients between 1992 and 2021 were reviewed. PLB found signs of rejection in 21.7% of cases (76/351), and moderate to severe fibrosis in 26.5% of cases (93/351). Overall, 264 PLB (75.2%) did not cause any changes to patient care. Immunosuppression was enhanced after 63 PLB, including 23 cases of occult rejection. The 1‐year PLB triggered significantly more changes, while biopsies at 15, 20, and 25 years produced the lowest rates of subsequent modifications. PLB had a significantly higher probability of inducing therapeutic changes if the patient had abnormal biological or imaging results (odds ratio [OR] 2.82 and 2.06), or a recent history of rejection or bacterial infection (OR 2.22 and 2.03).
Conclusion
Our results suggest that, although it often does not prompt any treatment changes, PLB could be performed because of its ability to detect silent rejection requiring an increase in immunosuppression. PLB could be carried out 1, 5, and 10 years after LT and then every 10 years in patients with normal biological and imaging results and no recent complications, while other patients could be kept on a 5‐year protocol.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pediatric Hepatogastroenterology and Nutrition, Femme-Mère-Enfant Hospital, Hospices Civils de Lyon, Lyon, France.
- Department of Digestive Diseases, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France.
- University Claude Bernard Lyon 1, Lyon, France.
- Department of Pathology, Hospices Civils de Lyon, Lyon, France.
- Institut Gustave Roussy, Department of Pathology, Villejuif and Université Paris Saclay, France.
ORCID profiles: Emma Wischlen, Jérôme Dumortier
Cite
APA
Wischlen, E., Boillot, O., Rivet, C., Lachaux, A., Bouvier, R., Hervieu, V., Scoazec, J. Y., Collardeau-Frachon, S., Dumortier, J., & Laverdure, N. (2023). Are protocol graft biopsies after pediatric liver transplantation useful? Experience in a single center over 20 years. Clinical Transplantation. https://doi.org/10.1111/ctr.14898
Vancouver
Wischlen E, Boillot O, Rivet C, Lachaux A, Bouvier R, Hervieu V, et al. Are protocol graft biopsies after pediatric liver transplantation useful? Experience in a single center over 20 years. Clinical Transplantation. 2023. doi:10.1111/ctr.14898
BibTeX
@article{Wischlen2023,
author = {Wischlen, Emma and Boillot, Olivier and Rivet, Christine and Lachaux, Alain and Bouvier, Raymonde and Hervieu, Valérie and Scoazec, Jean-Yves and Collardeau-Frachon, Sophie and Dumortier, Jérôme and Laverdure, Noémie},
title = {Are protocol graft biopsies after pediatric liver transplantation useful? Experience in a single center over 20 years},
journal = {Clinical Transplantation},
year = {2023},
doi = {10.1111/ctr.14898}
}
EUVIMED